Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3 Downgrades of Note

Published 09/21/2022, 04:39 PM
Updated 09/21/2022, 04:41 PM
© Reuters 3 Downgrades of Note

By Davit Kirakosyan

Today, several brokerages downgraded the shares of three companies, including Cisco (NASDAQ:CSCO), Micron Technology (NASDAQ:MU), and Sotera Health Co (NASDAQ:SHC). Below, we provided the details for each downgrade:

Barclays downgraded Cisco to Equalweight from Overweight and lowered its price target to $46.00 from $56.00. According to the analysts, the company doubled its cloud business relative share from 2019 to 2021, but has since stalled. The analysts believe the move to a more software-based model has been slow, and product backlog growth has been a negative impact. Furthermore, the analysts see the company more vulnerable to macro and enterprise risks.

Mizuho Securities downgraded Micron Technology to Neutral from Buy and lowered its price target to $56.00 from $75.00 as its recent checks show steepening price declines into Dec-quarter and H1/23. Moreover, the analysts noted that key data center/server markets are starting to show weakness, with softening demand in China/Europe and slowing CPU/GPU ramps.

JPMorgan downgraded Sotera Health to Underweight from Overweight and lowered its price target to $9.00 from $26.00.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.